trichostatin-a and von-Hippel-Lindau-Disease

trichostatin-a has been researched along with von-Hippel-Lindau-Disease* in 1 studies

Other Studies

1 other study(ies) available for trichostatin-a and von-Hippel-Lindau-Disease

ArticleYear
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.
    Nature medicine, 2001, Volume: 7, Issue:4

    Low oxygen tension influences tumor progression by enhancing angiogenesis; and histone deacetylases (HDAC) are implicated in alteration of chromatin assembly and tumorigenesis. Here we show induction of HDAC under hypoxia and elucidate a role for HDAC in the regulation of hypoxia-induced angiogenesis. Overexpressed wild-type HDAC1 downregulated expression of p53 and von Hippel-Lindau tumor suppressor genes and stimulated angiogenesis of human endothelial cells. A specific HDAC inhibitor, trichostatin A (TSA), upregulated p53 and von Hippel-Lindau expression and downregulated hypoxia-inducible factor-1alpha and vascular endothelial growth factor. TSA also blocked angiogenesis in vitro and in vivo. TSA specifically inhibited hypoxia-induced angiogenesis in the Lewis lung carcinoma model. These results indicate that hypoxia enhances HDAC function and that HDAC is closely involved in angiogenesis through suppression of hypoxia-responsive tumor suppressor genes.

    Topics: Animals; Cattle; Cell Line; DNA-Binding Proteins; Endothelial Growth Factors; Enzyme Inhibitors; Gene Expression Regulation; Genes, p53; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphokines; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Nuclear Proteins; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; von Hippel-Lindau Disease

2001